Nothing Special   »   [go: up one dir, main page]

ECSP982660A - USE OF PTHrP ANALOGS IN FRACTURE HEALING - Google Patents

USE OF PTHrP ANALOGS IN FRACTURE HEALING

Info

Publication number
ECSP982660A
ECSP982660A ECSP982660A ECSP982660A EC SP982660 A ECSP982660 A EC SP982660A EC SP982660 A ECSP982660 A EC SP982660A EC SP982660 A ECSP982660 A EC SP982660A
Authority
EC
Ecuador
Prior art keywords
fracture healing
pthrp analogs
bone healing
fracture repair
pthrkp
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Brian Henry Vickery
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982660 priority Critical patent/ECSP982660A/en
Publication of ECSP982660A publication Critical patent/ECSP982660A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona métodos de cicatrización de hueso y reparación de fracturas que comprenden la administración a un paciente que lo necesita de una cantidad eficaz de un análogo popipeptidico del péptido relacionado con la hormona paratiroidea (PTHrKP) y de sales del mismo, en el cual los residuos aminoacidicos 22-31 forman una élice alfa anfipática, o el uso de dicho polipéptido para la preparación de un medicamento para el tratamiento de cicatrización de hueso y reparación de fracturas.The present invention provides methods of bone healing and fracture repair comprising administration to a patient in need of an effective amount of a parathyroid hormone-related peptide (PTHrKP) popypeptide analog, in which amino acid residues 22-31 form an amphipathic alpha elice, or the use of said polypeptide for the preparation of a medicament for the treatment of bone healing and fracture repair.

ECSP982660 1998-09-08 1998-09-08 USE OF PTHrP ANALOGS IN FRACTURE HEALING ECSP982660A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982660 ECSP982660A (en) 1998-09-08 1998-09-08 USE OF PTHrP ANALOGS IN FRACTURE HEALING

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982660 ECSP982660A (en) 1998-09-08 1998-09-08 USE OF PTHrP ANALOGS IN FRACTURE HEALING

Publications (1)

Publication Number Publication Date
ECSP982660A true ECSP982660A (en) 1999-04-16

Family

ID=42043580

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982660 ECSP982660A (en) 1998-09-08 1998-09-08 USE OF PTHrP ANALOGS IN FRACTURE HEALING

Country Status (1)

Country Link
EC (1) ECSP982660A (en)

Similar Documents

Publication Publication Date Title
AR015435A1 (en) USE OF A PEPTID POLYPEPTIDE ANALOG RELATED TO PARTIROID HORMONE (PTHRP) AND SALTS OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT.
ES2190244T3 (en) USE OF THE PARTIROID HORMONE CONSTITUTED BY A SEQUENCE OF AMINO ACIDS 1-34 OF THE HUMAN PARTIROID HORMONE TO REDUCE THE RISK OF VERTEBRAL AND NON-VERTEBRAL BONE FRACTURES.
AR024074A1 (en) ABETA FRAGMENT JOINED WITH A BEARING PEPTIDE TO PREVENT OR TREAT DISEASES ASSOCIATED WITH ABETA AMILOID DEPOSITS, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND ITS USE IN THE PREPARATION OF MEDICINES.
CO5090908A1 (en) PROCEDURE FOR MANAGING INSULINOTROPIC PEPTIDES
MX9402339A (en) PROTEIN FORMULATION.
HUP0100928A2 (en) Methods for treatment of diabetes using peptide analogues of insulin
HUP0003349A2 (en) Peptide parathyroid hormone analogs, pharmaceutical compositions comprising thereof and their use
AR023806A1 (en) USE OF A PEPTIDE MIXTURE FOR THE MANUFACTURE OF A THERAPEUTIC AGENT FOR PROFILAXIS AND / OR CANCER TREATMENT, PHARMACEUTICAL COMPOSITIONS AND VACCINES CONTAINING SUCH MIXTURE AND THE PROCEDURES FOR PREPARATION OF THESE COMPOSITIONS
ES2145997T3 (en) AMINO ACID COMPOSITIONS AND THE USE OF THE SAME IN CLINICAL NUTRITION.
ES2927067T3 (en) Abaloparatide combined with alendronate for the reduction of non-vertebral bone fractures
AR062775A1 (en) PHARMACEUTICAL COMPOSITION ABLE TO IMPROVE THE ACTIVITY OF LPG -1 IN A HUMAN BEING AND ITS USE TO PREPARE A MEDICINAL PRODUCT
CO6260151A2 (en) PEPTIDE OF CDH3 AND MEDICINAL AGENT UNDERSTANDING
AR003589A1 (en) USE OF AN EFFECTIVE AMOUNT OF AT LEAST ONE PEPTIDE IN A COSMETIC COMPOSITION OR FOR THE PREPARATION OF A MEDICATION INTENDED TO PARATRATE INFLAMMATION, AND A COSMETIC TREATMENT PROCEDURE THROUGH A COSMETIC COMPOSITION CONTAINING SUCH PEPTIDE.
DK0470117T3 (en) Use of "calcitonin gene-related peptides" for the manufacture of drugs for the treatment of erectile dysfunctions
PT1001802E (en) COMBINED PHARMACEUTICAL PREPARATION UNDERSTANDING PARTIROID HORMONE AND A REBORN INHIBITOR OSSEA
DE69838647D1 (en) TREATMENT OF GRAVITY
WO2004009625A3 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF α-SYNUCLEIN-RELATED DISEASES
CO5570658A2 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF DIABETES
TW200511999A (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
ECSP982660A (en) USE OF PTHrP ANALOGS IN FRACTURE HEALING
RU2005131578A (en) APLIDINE FOR TREATMENT OF MULTIPLE MYELOMA
BR0109279A (en) Lhrh antagonists, their preparation and application as a medicine
AR036591A1 (en) USE OF HL IN CONTROLLED OVARIC HYPERESTIMULATION
AR014082A1 (en) ORAL SERTRALINE CONCENTRATE
YU60199A (en) New bpc peptide salts with organo-protective activity,the process for their preparation and their use in therapy